PMC:7144273 / 1644-4559
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T28 | 17-28 | NCBITaxon:11118 | denotes | coronavirus |
T29 | 43-51 | SP_7 | denotes | COVID-19 |
T30 | 241-253 | SP_7 | denotes | severe acute |
T31 | 254-265 | SP_7;UBERON:0001004 | denotes | respiratory |
T32 | 266-288 | SP_7 | denotes | syndrome coronavirus 2 |
T33 | 290-300 | SP_7 | denotes | SARS-CoV-2 |
T34 | 319-322 | BV_22 | denotes | RNA |
T35 | 323-328 | BV_22;NCBITaxon:10239 | denotes | virus |
T36 | 336-349 | NCBITaxon:11118 | denotes | Coronaviridae |
T37 | 350-355 | NCBITaxon:10239 | denotes | virus |
T38 | 364-369 | SP_6;NCBITaxon:9606 | denotes | Human |
T39 | 373-378 | SP_6;NCBITaxon:9606 | denotes | human |
T40 | 407-418 | UBERON:0001004 | denotes | respiratory |
T41 | 561-578 | UBERON:0000065 | denotes | respiratory tract |
T42 | 677-688 | UBERON:0001004 | denotes | respiratory |
T43 | 909-917 | SP_7 | denotes | COVID-19 |
T44 | 1012-1017 | UBERON:0000062 | denotes | organ |
T45 | 1093-1098 | NCBITaxon:10239 | denotes | viral |
T46 | 1321-1331 | DG_28 | denotes | remdesivir |
T47 | 1333-1342 | DG_23 | denotes | lopinavir |
T48 | 1343-1352 | DG_30 | denotes | ritonavir |
T49 | 1357-1366 | DG_23 | denotes | lopinavir |
T50 | 1367-1376 | DG_30 | denotes | ritonavir |
T51 | 1485-1495 | DG_28 | denotes | Remdesivir |
T52 | 1500-1505 | PR:000008924 | denotes | IFN-β |
T53 | 1554-1563 | DG_23;NCBITaxon:11646 | denotes | lopinavir |
T54 | 1568-1578 | DG_28 | denotes | remdesivir |
T55 | 1608-1619 | UBERON:0001004 | denotes | respiratory |
T56 | 1630-1634 | SP_9 | denotes | MERS |
T57 | 1636-1647 | NCBITaxon:11118 | denotes | coronavirus |
T58 | 1681-1691 | SP_7 | denotes | SARS-CoV-2 |
T59 | 1729-1733 | CHEBI:33290;CHEBI:33290 | denotes | Food |
T60 | 1738-1742 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
T61 | 1793-1811 | CHEBI:5801;CHEBI:5801;DG_20 | denotes | hydroxychloroquine |
T62 | 1815-1823 | SP_7 | denotes | COVID-19 |
T63 | 1915-1920 | NCBITaxon:10239 | denotes | virus |
T64 | 1951-1956 | UBERON:0000170 | denotes | lungs |
T65 | 2199-2210 | CL:0000134;UBERON:0003104 | denotes | mesenchymal |
T66 | 2211-2215 | CL:0002540 | denotes | stem |
T67 | 2217-2224 | CL:0000499;UBERON:0003891 | denotes | stromal |
T68 | 2233-2237 | DG_47 | denotes | MSCs |
T69 | 2291-2313 | GO:1903561 | denotes | extracellular vesicles |
T70 | 2377-2385 | SP_7 | denotes | COVID-19 |
T71 | 2386-2397 | GO:0045333 | denotes | respiratory |
T72 | 2601-2612 | UBERON:0001004 | denotes | respiratory |
T73 | 2613-2618 | NCBITaxon:10239 | denotes | viral |
T74 | 2669-2680 | UBERON:0001004 | denotes | respiratory |
T75 | 2681-2686 | NCBITaxon:10239 | denotes | virus |
T2084 | 17-28 | NCBITaxon:11118 | denotes | coronavirus |
T24757 | 43-51 | SP_7 | denotes | COVID-19 |
T77433 | 241-253 | SP_7 | denotes | severe acute |
T25240 | 254-265 | SP_7;UBERON:0001004 | denotes | respiratory |
T61821 | 266-288 | SP_7 | denotes | syndrome coronavirus 2 |
T51488 | 290-300 | SP_7 | denotes | SARS-CoV-2 |
T72346 | 319-322 | BV_22 | denotes | RNA |
T63541 | 323-328 | BV_22;NCBITaxon:10239 | denotes | virus |
T63057 | 336-349 | NCBITaxon:11118 | denotes | Coronaviridae |
T74239 | 350-355 | NCBITaxon:10239 | denotes | virus |
T50871 | 364-369 | SP_6;NCBITaxon:9606 | denotes | Human |
T8899 | 373-378 | SP_6;NCBITaxon:9606 | denotes | human |
T56974 | 407-418 | UBERON:0001004 | denotes | respiratory |
T74650 | 561-578 | UBERON:0000065 | denotes | respiratory tract |
T87761 | 677-688 | UBERON:0001004 | denotes | respiratory |
T42553 | 909-917 | SP_7 | denotes | COVID-19 |
T52691 | 1012-1017 | UBERON:0000062 | denotes | organ |
T41920 | 1093-1098 | NCBITaxon:10239 | denotes | viral |
T27259 | 1321-1331 | DG_28 | denotes | remdesivir |
T8475 | 1333-1342 | DG_23 | denotes | lopinavir |
T44553 | 1343-1352 | DG_30 | denotes | ritonavir |
T42287 | 1357-1366 | DG_23 | denotes | lopinavir |
T22890 | 1367-1376 | DG_30 | denotes | ritonavir |
T44456 | 1485-1495 | DG_28 | denotes | Remdesivir |
T64865 | 1500-1505 | PR:000008924 | denotes | IFN-β |
T84174 | 1554-1563 | DG_23;NCBITaxon:11646 | denotes | lopinavir |
T82214 | 1568-1578 | DG_28 | denotes | remdesivir |
T74336 | 1608-1619 | UBERON:0001004 | denotes | respiratory |
T80235 | 1630-1634 | SP_9 | denotes | MERS |
T53486 | 1636-1647 | NCBITaxon:11118 | denotes | coronavirus |
T31435 | 1681-1691 | SP_7 | denotes | SARS-CoV-2 |
T4055 | 1729-1733 | CHEBI:33290;CHEBI:33290 | denotes | Food |
T94978 | 1738-1742 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
T36847 | 1793-1811 | CHEBI:5801;CHEBI:5801;DG_20 | denotes | hydroxychloroquine |
T71772 | 1815-1823 | SP_7 | denotes | COVID-19 |
T17314 | 1915-1920 | NCBITaxon:10239 | denotes | virus |
T53851 | 1951-1956 | UBERON:0000170 | denotes | lungs |
T25000 | 2199-2210 | CL:0000134;UBERON:0003104 | denotes | mesenchymal |
T85100 | 2211-2215 | CL:0002540 | denotes | stem |
T38762 | 2217-2224 | CL:0000499;UBERON:0003891 | denotes | stromal |
T37614 | 2233-2237 | DG_47 | denotes | MSCs |
T31115 | 2291-2313 | GO:1903561 | denotes | extracellular vesicles |
T19560 | 2377-2385 | SP_7 | denotes | COVID-19 |
T12176 | 2386-2397 | GO:0045333 | denotes | respiratory |
T3124 | 2601-2612 | UBERON:0001004 | denotes | respiratory |
T63910 | 2613-2618 | NCBITaxon:10239 | denotes | viral |
T61343 | 2669-2680 | UBERON:0001004 | denotes | respiratory |
T19925 | 2681-2686 | NCBITaxon:10239 | denotes | virus |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T10 | 319-322 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T11 | 561-578 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T12 | 1012-1017 | Body_part | denotes | organ | http://purl.org/sig/ont/fma/fma67498 |
T13 | 1929-1937 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T14 | 1951-1956 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T15 | 2047-2058 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
T16 | 2060-2062 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
T17 | 2074-2078 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
T18 | 2074-2076 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
T19 | 2157-2161 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T20 | 2226-2231 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T21 | 2332-2336 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T22 | 2871-2875 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T3 | 561-578 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T4 | 1012-1017 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T17 | 17-41 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T18 | 43-51 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T19 | 241-288 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T20 | 241-274 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T21 | 290-298 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T22 | 290-294 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 561-588 | Disease | denotes | respiratory tract infection | http://purl.obolibrary.org/obo/MONDO_0024355 |
T24 | 579-588 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T25 | 657-666 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T26 | 671-706 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T27 | 677-706 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T28 | 708-712 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T29 | 909-917 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T30 | 939-943 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T31 | 1003-1025 | Disease | denotes | multiple organ failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T32 | 1093-1108 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T33 | 1099-1108 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T34 | 1276-1286 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T35 | 1681-1689 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T36 | 1681-1685 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T37 | 1815-1823 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T38 | 2377-2385 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T39 | 2386-2405 | Disease | denotes | respiratory disease | http://purl.obolibrary.org/obo/MONDO_0005087 |
T40 | 2613-2629 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T41 | 2681-2697 | Disease | denotes | virus infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T42 | 2775-2779 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 323-328 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T22 | 350-355 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T23 | 364-369 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T24 | 373-378 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T25 | 515-522 | http://purl.obolibrary.org/obo/CLO_0053001 | denotes | 1 to 14 |
T26 | 800-805 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 2% [2 |
T27 | 1012-1017 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
T28 | 1069-1070 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T29 | 1542-1550 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T30 | 1764-1767 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T31 | 1915-1920 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T32 | 1951-1956 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T33 | 2110-2111 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T34 | 2157-2161 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T35 | 2216-2231 | http://purl.obolibrary.org/obo/CL_0000499 | denotes | (stromal) cells |
T36 | 2332-2342 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell types |
T37 | 2426-2427 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T38 | 2681-2686 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T39 | 2871-2875 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1321-1331 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T2 | 1333-1342 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T3 | 1343-1352 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T4 | 1357-1366 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T5 | 1367-1376 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T6 | 1381-1391 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T7 | 1393-1396 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
T8 | 1500-1503 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
T9 | 1532-1541 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T10 | 1554-1563 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T11 | 1568-1578 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T12 | 1793-1811 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T13 | 2060-2062 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T15 | 2074-2076 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1093-1108 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
T2 | 1974-1986 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
T3 | 2613-2629 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T3 | 561-588 | Phenotype | denotes | respiratory tract infection | http://purl.obolibrary.org/obo/HP_0011947 |
T4 | 621-626 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T5 | 637-642 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T6 | 657-666 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T7 | 677-697 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T8 | 993-998 | Phenotype | denotes | shock | http://purl.obolibrary.org/obo/HP_0031273 |
T9 | 1929-1943 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32265310-31978945-29390428 | 214-215 | 31978945 | denotes | 1 |
32265310-31978945-29390429 | 454-455 | 31978945 | denotes | 1 |
32265310-31924756-29390430 | 804-805 | 31924756 | denotes | 2 |
32265310-31924756-29390431 | 1718-1719 | 31924756 | denotes | 2 |
32265310-32192578-29390432 | 2091-2092 | 32192578 | denotes | 3 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32265310-31978945-29390428 | 214-215 | 31978945 | denotes | 1 |
32265310-31978945-29390429 | 454-455 | 31978945 | denotes | 1 |
32265310-31924756-29390430 | 804-805 | 31924756 | denotes | 2 |
32265310-31924756-29390431 | 1718-1719 | 31924756 | denotes | 2 |
32265310-32192578-29390432 | 2091-2092 | 32192578 | denotes | 3 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-12 | Sentence | denotes | Introduction |
T13 | 13-217 | Sentence | denotes | The coronavirus disease 2019 (COVID-19) pandemic, originating in Wuhan, China, is rapidly and continuously spreading globally and can result in serious significant respiratory morbidity and mortality [1]. |
T14 | 218-363 | Sentence | denotes | The responsible agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an enveloped RNA virus of the Coronaviridae virus family. |
T15 | 364-457 | Sentence | denotes | Human-to-human transmission occurs through respiratory droplets or contaminated surfaces [1]. |
T16 | 458-528 | Sentence | denotes | The average incubation period is 5 days, but ranges from 1 to 14 days. |
T17 | 529-649 | Sentence | denotes | Most patients present with mild respiratory tract infection, most commonly characterised by fever (82%) and cough (81%). |
T18 | 650-807 | Sentence | denotes | Severe pneumonia and acute respiratory distress syndrome (ARDS) have been described in 14% of the reported cases, and the overall mortality is around 2% [2]. |
T19 | 808-904 | Sentence | denotes | However, these numbers are evolving as the pandemic spreads, and depend on the country involved. |
T20 | 905-1170 | Sentence | denotes | For COVID-19 patients who develop ARDS requiring intubation and mechanical ventilation, shock and multiple organ failure can also develop, although whether this is a direct consequence of viral infection or due to complications of critical illness is not yet clear. |
T21 | 1171-1287 | Sentence | denotes | Current therapeutic approaches include aggressive standard supportive care and treatment of any other co-infections. |
T22 | 1288-1484 | Sentence | denotes | Antiviral medications, including remdesivir, lopinavir–ritonavir, or lopinavir–ritonavir and interferon (IFN)-β1, are under investigation but safety and potential efficacy remain to be determined. |
T23 | 1485-1721 | Sentence | denotes | Remdesivir and IFN-β1β appear to have superior antiviral activity to lopinavir and remdesivir in vitro for the Middle East respiratory syndrome (MERS) coronavirus but whether this is the case for SARS-CoV-2 remains to be determined [2]. |
T24 | 1722-1875 | Sentence | denotes | The US Food and Drug Administration (FDA) has recently approved use of hydroxychloroquine in COVID-19 patients but the efficacy remains to be determined. |
T25 | 1876-2094 | Sentence | denotes | Growing information also suggests that virus-induced cytokine storm in the lungs may drive severe pathogenesis and provide potential therapeutic targets, for example anti-interleukin (IL)-6 or anti-IL-1 approaches [3]. |
T26 | 2095-2406 | Sentence | denotes | More recently, a growing number of clinical investigations of cell-based therapies, primarily involving mesenchymal stem (stromal) cells (MSCs) but also utilising MSC-derived conditioned media or extracellular vesicles and several other cell types, have been initiated in China for COVID-19 respiratory disease. |
T27 | 2407-2630 | Sentence | denotes | As these encompass a wide range of approaches and targeted patient groups, it is imperative to better understand the rationale of the studies and the potential mechanisms of MSC actions towards respiratory viral infections. |
T28 | 2631-2915 | Sentence | denotes | Recent pre-clinical data in models of respiratory virus infections and relevant related clinical studies of MSC administration in patients with ARDS can contribute to better definition of the patient population for whom potential MSC-based cell therapy approaches might be considered. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
66 | 241-300 | Species | denotes | severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 | Tax:2697049 |
67 | 336-349 | Species | denotes | Coronaviridae | Tax:11118 |
68 | 364-369 | Species | denotes | Human | Tax:9606 |
69 | 373-378 | Species | denotes | human | Tax:9606 |
70 | 534-542 | Species | denotes | patients | Tax:9606 |
71 | 177-188 | Species | denotes | respiratory | Tax:12814 |
72 | 407-418 | Species | denotes | respiratory | Tax:12814 |
74 | 203-212 | Disease | denotes | mortality | MESH:D003643 |
75 | 561-588 | Disease | denotes | respiratory tract infection | MESH:D012141 |
76 | 621-626 | Disease | denotes | fever | MESH:D005334 |
77 | 637-642 | Disease | denotes | cough | MESH:D003371 |
78 | 657-666 | Disease | denotes | pneumonia | MESH:D011014 |
79 | 671-706 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
80 | 708-712 | Disease | denotes | ARDS | MESH:D012128 |
81 | 780-789 | Disease | denotes | mortality | MESH:D003643 |
104 | 1381-1401 | Gene | denotes | interferon (IFN)-β1, | Gene:3456 |
105 | 2047-2065 | Gene | denotes | interleukin (IL)-6 | Gene:3569 |
106 | 2074-2078 | Gene | denotes | IL-1 | Gene:3552 |
107 | 918-926 | Species | denotes | patients | Tax:9606 |
108 | 1596-1647 | Species | denotes | Middle East respiratory syndrome (MERS) coronavirus | Tax:1335626 |
109 | 1681-1691 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
110 | 1824-1832 | Species | denotes | patients | Tax:9606 |
111 | 1321-1331 | Chemical | denotes | remdesivir | MESH:C000606551 |
112 | 1333-1352 | Chemical | denotes | lopinavir–ritonavir | MESH:C558899 |
113 | 1357-1376 | Chemical | denotes | lopinavir–ritonavir | MESH:C558899 |
114 | 1485-1495 | Chemical | denotes | Remdesivir | MESH:C000606551 |
115 | 1554-1563 | Chemical | denotes | lopinavir | MESH:D061466 |
116 | 1568-1578 | Chemical | denotes | remdesivir | MESH:C000606551 |
117 | 1793-1811 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
118 | 909-917 | Disease | denotes | COVID-19 | MESH:C000657245 |
119 | 939-943 | Disease | denotes | ARDS | MESH:D012128 |
120 | 993-998 | Disease | denotes | shock | MESH:D012769 |
121 | 1003-1025 | Disease | denotes | multiple organ failure | MESH:D009102 |
122 | 1093-1108 | Disease | denotes | viral infection | MESH:D001102 |
123 | 1136-1152 | Disease | denotes | critical illness | MESH:D016638 |
124 | 1273-1286 | Disease | denotes | co-infections | MESH:D060085 |
125 | 1815-1823 | Disease | denotes | COVID-19 | MESH:C000657245 |
140 | 2130-2138 | Species | denotes | clinical | Tax:191496 |